|
HS Code |
116298 |
| Chemical Name | 4-Bromomethyl-2-Cyanobiphenyl |
| Molecular Formula | C14H10BrN |
| Cas Number | 142888-38-0 |
| Appearance | White to off-white solid |
| Purity | Typically >98% |
| Solubility | Slightly soluble in organic solvents |
| Smiles | N#Cc1ccc(cc1)-c2ccccc2CBr |
| Inchi | InChI=1S/C14H10BrN/c15-9-12-6-5-8-13(10-12)14(16)11-3-1-2-4-11/h1-6,8,10H,9H2 |
| Storage Conditions | Store at 2-8°C, protect from light |
| Hazard Statements | May cause irritation to eyes, skin, and respiratory tract |
| Synonyms | 2-Cyano-4'-bromomethylbiphenyl |
As an accredited 4-Bromomethyl-2-Cyanobiphenyl factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | A 5-gram amber glass bottle with a tamper-evident cap and hazard labels, clearly marked "4-Bromomethyl-2-Cyanobiphenyl." |
| Shipping | 4-Bromomethyl-2-Cyanobiphenyl is shipped in tightly sealed, chemical-resistant containers to prevent leaks and contamination. It is transported as a hazardous material according to international regulations. Packages are securely labeled, and shipping documentation includes safety and handling instructions. Ensure storage in a cool, dry area, away from incompatible substances during transit. |
| Storage | 4-Bromomethyl-2-cyanobiphenyl should be stored in a tightly sealed container, in a cool, dry, and well-ventilated area, away from sources of ignition and incompatible materials such as strong oxidizers. Keep it protected from light and moisture. Ensure that the storage area has proper chemical shelving and clear labeling, and restrict access to trained personnel wearing appropriate protective equipment. |
Applications of 4-Bromomethyl-2-Cyanobiphenyl in Industrial Manufacturing4-Bromomethyl-2-Cyanobiphenyl is a high-purity intermediate essential for complex molecule construction in advanced synthesis routes. As a manufacturer, we supply the pharmaceutical, agrochemical, materials, and liquid crystal industries, supporting high-volume and niche formulations with controlled quality and traceability throughout the supply chain. 1. Pharmaceutical API Intermediate SynthesisThis compound serves as a critical intermediate in the synthesis of active pharmaceutical ingredients (APIs), especially those targeting central nervous system and oncology indications. Pharmaceutical producers use it for Suzuki coupling or nitrile-derivation routes, with controlled reactivity and high selectivity. Stringent traceability and impurity thresholds apply in each batch to meet final drug standards. Partners typically require full documentation packages, including residual solvent and elemental impurity data, for each lot released. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
2. Liquid Crystal Material PrecursorThis compound forms a key building block in the production of specific biphenyl-based liquid crystal materials for advanced display technologies. Its functionalization supports the fine-tuning of birefringence, viscosity, and dielectric properties, particularly valued by manufacturers of high-resolution LCD and OLED screens. The raw material must conform to ultra-low metal, halogen, and particle content, with controlled isomer purity to maintain performance consistency in end devices. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. Agrochemical Active Ingredient IntermediateManufacturers in the agrochemical sector utilize this material as an advanced intermediate for the preparation of certain acylanilide and biphenyl herbicides as well as fungicides. Each production requires strict adherence to batch-to-batch consistency, ensuring that unreacted bromides or nitriles are sufficiently removed. Reactivity and purity affect not only synthetic yield but also environmental compliance and final product toxicity profiles, driving needs for in-depth process analytics in every lot shipped. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. Advanced Functional Polymer SynthesisPolymer producers deploy this product as a reactive site initiator for the synthesis of high-performance specialty polymers and copolymers that require strong thermal stability and selective electrical conductivity. Its bromo and cyano functionalities allow for precise grafting and controlled polymer growth via atom transfer radical polymerization (ATRP) or nucleophilic substitution, resulting in advanced engineering materials for electronics and membrane manufacture. Rigorous supply chain controls ensure low residual solvents and absence of unreacted monomer for downstream customer qualification audits. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
5. Specialty Chemical Intermediate for Dye and Pigment ManufacturingProducers in the colorant industry use this compound as a precursor for synthesizing high-stability, biphenyl-based dyes and pigments, especially those requiring resistance to ultraviolet radiation and chemical stress in stringent environmental conditions. The raw material supports various coupling and substitution chemistries to create chromophores with sharp absorption maxima, demanded by customers for automotive coatings, specialty inks, and fiber dye applications. Purity and uniform isomer distribution directly impact hue and batch reproducibility in large-scale pigment production lines. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive 4-Bromomethyl-2-Cyanobiphenyl prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
In our day-to-day manufacturing operations, certain molecules bring a lot to the table for our customers in pharmaceuticals and advanced material development. Among them, 4-Bromomethyl-2-cyanobiphenyl stands out as a robust intermediate for those working with complex organic syntheses. We synthesize this compound ourselves, carefully selecting raw materials and process routes to deliver the product batch after batch with a consistency chemists and engineers can count on.
In the plant, 4-Bromomethyl-2-cyanobiphenyl is referenced by many as a functionalized biphenyl derivative. The model we produce keeps the core biphenyl backbone, with a bromomethyl substituent at the para position and a nitrile at the ortho site of one ring. You will recognize our 4-Bromomethyl-2-cyanobiphenyl by the efficient placement of these groups: the bromomethyl moiety enables easy access for nucleophilic substitution reactions, while the nitrile functions as a synthetic handle in further transformations. When we pull samples at the end of a production run, they show a pale to off-white powder by eye, a detail our QC team checks before approving a lot for packaging.
Each batch passes through gas chromatography-mass spectrometry as well as NMR and FT-IR spectroscopy. These instruments confirm the molecular fingerprint: two phenyl rings joined in biphenyl fashion, a cyano group set ortho to that bond, and the critical bromomethyl at the para site. Crystallization and purification decisions we make in the plant directly impact the yield and purity, and we report typical assay values well above 98% by HPLC, a detail much less common among re-sellers or smaller preparative labs.
Many downstream reactions depend on this level of purity. In pharmaceutical intermediate synthesis, carrying over trace byproducts or over-brominated species can confound later transformations and scale-up runs. We focus on reproducibility from kilo scale through to regular production campaigns, since both research and commercial process chemists rely on every bottle or drum acting exactly like the last. Through every distillation and chromatography cycle, our team keeps an eye on residual solvent content and moisture to ensure customers are not hampered by stray contaminants.
The structure makes this compound especially suited for Suzuki cross-coupling, Grignard reactions, and nucleophilic substitution. Many of our customers use the bromomethyl group for installation of amines, ethers, and other sidechains, each tailored to downstream pharmaceutical targets or small-molecule libraries. The ortho-cyano group often increases the rigidity of the biphenyl framework or participates in additional cyclizations, depending on the final use case. Such design freedom is why this intermediate has outpaced many older, less flexible biphenyl bromides.
As a chemical manufacturer, we work closely with chemists to understand the performance they expect. Feedback from the field has pushed us to optimize our process so the typical impurity profile is predictable and easily managed during scale up. By observing trends in demand and tracking research publications, we stay on top of evolving application spaces for this molecule, such as newly patented small-molecule actives or advanced materials used in liquid crystal displays and organic electronic devices.
We see our share of challenges manufacturing 4-Bromomethyl-2-cyanobiphenyl. Brominating methylbiphenyl while suppressing overbromination is unwieldy if parameters are uncontrolled. Introducing the nitrile can create regioisomeric byproducts if selectivity drops, so our technicians monitor reaction temperatures and reagent qualities throughout the operation. Analytical staff track these outcomes in near-real-time, making adjustments before deviations can propagate down the line. Unlike traders or brokers who never witness the labor of synthesis, we experience firsthand the pain of a rejected batch or a supply interruption due to raw material volatility.
From our main site, we run solvent recovery, waste minimization, and closed-loop father liquor recycling as part of the production. This brings cost reduction and environmental performance into alignment—two demands now common from large end-users and regulators alike. We understand the ripple effect that a few grams per liter of solvent residue or a 2% drop in yield can cause in an active pharmaceutical ingredient facility buying this intermediate. To address this, we schedule frequent collaborative meetings with process engineers and QA teams to fine-tune procedures and improve output stability.
Buyers ask what separates product direct from a manufacturer versus from other channels. Besides obvious traceability to batch records and certificates of analysis customized for each run, we present technical dossiers unique to our in-house process. Our plant tracks lot data, stability studies at ambient and refrigerated conditions, and possible residuals from consumables unique to our synthesis approach. End-users see these records during audits and regulatory filings, gaining confidence not only in the purity but in the repeatability they require for consistent research or manufacturing workflows.
Resellers may promote similar-sounding products, but their wares often lack direct data on long-term storage stability, comprehensive impurity profiles, or reproducible lot-to-lot performance. Our customers have told us stories of untracked cold shipments leading to product clumping or breakdown; as a manufacturer, we control and document shipping conditions and response times tightly to mitigate such risks. Alongside QC analyses, we always include batch retention samples—physical proof of what actually shipped—so any future questions about historical material can be answered quickly and unambiguously.
Research chemists use 4-Bromomethyl-2-cyanobiphenyl in development of kinase inhibitors, novel anti-inflammatories, and specialty ligands for transition metal catalysis. Since the bromomethyl position reacts efficiently with nucleophiles, new side chains can be added smoothly; the biphenyl scaffold survives harsh reaction conditions without twisting or degrading, and the cyano group opens creative cyclization or acylation strategies. Our product’s uniformity at >98% purity means researchers do not need to spend time repeatedly purifying intermediates, which accelerates SAR studies and allows more time for creative investigation.
On scale-up lines, 4-Bromomethyl-2-cyanobiphenyl often forms the backbone in lead compound synthesis right through pilot and commercial production. We supply technical teams at larger plants with data on optimal dissolution in common solvents, compatibility with metal catalysts, and degradation pathways under elevated temperatures. Since trace bromide, unreacted starting material, or brominated biphenyl byproducts can negatively impact these steps, we retain detailed breakdowns of product profiles, including minor impurities identified by LC-MS and GC-MS. Our records demonstrate compliance with internal and external specifications at every stage, making it easier for QA auditors and regulatory affairs teams to close documentation gaps.
For custom manufacturing partners and pharmaceutical companies, batch consistency is non-negotiable. Lags, off-spec weights, or impurity drift can stall a campaign or even lead to regulatory headaches. We dedicate a portion of each production campaign to redrilling our isolation and drying procedures, including checks for water content and potential interaction with packaging materials. Whether shipping off 100-gram bottles for R&D or multi-kilo drums for production, our teams maintain a simple rule—the 1000th batch meets the same specification as the first.
We remember past incidents where early samples exposed unforeseen stability issues. Constant feedback and monitoring over the years has fine-tuned not just our synthesis methods but our storage and transport models. Our logs record excursions in temperature, humidity, and time-in-transit, providing a chain of custody both for our own records and our customer's due diligence.
Looking at historical practice, unsubstituted biphenyl, 4-bromomethylbiphenyl, and various nitro or amine-substituted biphenyls all find use in organic chemistry. Each brings benefits: some boast simpler preparation, some offer wide-ranging cross-coupling utility. With 4-Bromomethyl-2-cyanobiphenyl, researchers gain control over both electronic and steric properties with a single intermediate, setting a clear advantage in target-oriented synthesis and compound library expansion. Its already-functionalized nature means fewer steps are required compared to older biphenyl intermediates, and downstream purification is simplified by selective reactivity.
Other biphenyls may not offer the same opportunity for rapid attachment of complex moieties—the bromomethyl group almost universally outpaces alkyl or aryl halides for reaction rate and product purity. The cyano group not only adds new reactivity, but may improve solubility in polar aprotic solvents common to modern medicinal chemistry labs. Chemists working with us seldom switch back to less agile biphenyls except for legacy projects or where regulatory filings already lock in a historical reagent.
Pharmaceutical firms have filed patents listing 4-Bromomethyl-2-cyanobiphenyl as a core scaffold. Its structure has appeared in research literature supporting new therapies in oncology, central nervous system disorders, and inflammation. Our product routinely ends up as a core fragment in combinatorial libraries, a key intermediate before chiral resolution, or a platform for radiolabeling studies. Material scientists explore its incorporation into organic light-emitting diode (OLED) manufacture and other high-performance organic electronics, exploiting the stability of the biphenyl backbone.
These evolving application spaces drive our own sourcing and production cycles. As new publications and patents emerge, we adapt not only to higher volumes but also to special requests for custom impurity cutoffs, particle sizes, or alternative packaging to support varied research protocols. We see this as a two-way learning process: continual exchange with the field guides both incremental and major improvements in how we approach synthesis, handling, and shipment.
Working closely with process safety engineers, we follow strict protocols for handling and isolating 4-Bromomethyl-2-cyanobiphenyl. Researchers asked about residues and contamination risks—answering these questions draws on experience, not just generic safety data sheets. Our operations maintain separate lines and strong cleaning regimes to prevent cross-contamination with other aryl halides or nitrites, and we analyze every lot for trace heavy metals and halogenated solvents.
Operators and lab staff undergo regular training on the appropriate handling of reactive aryl bromides and cyanide precursors. Exposure limits and waste protocols follow established industry guidelines, but real safety performance comes only from daily vigilance and pragmatic hazard mitigation. Unlabeled cross-reactions or accidental mixing can ruin multiple batches at a time. That’s why we invest in strict chemical segregation and automated monitoring of environmental controls throughout our main plant.
Supply chain disruptions in the past few years have reminded us how crucial upstream traceability and redundancy are for specialty intermediates like 4-Bromomethyl-2-cyanobiphenyl. Our direct relationships with both chemical feedstock producers and logistics providers mean we can secure raw materials in fluctuating markets, offering our customers added confidence that their shipments will arrive on schedule.
For those purchasing large volumes, we map out long-term supply forecasts based on regional trends in pharmaceutical launches or electronics product rollouts. Experience shows that spikes in demand can temporarily choke supply of precursor chemicals, so we pre-book extra production slots and store safety stock. Unlike broker or trader networks, we react immediately—whether by shifting batch schedules, contracting toll manufacturers for overflow, or modifying production parameters in real-time to accommodate sudden order upticks.
As scrutiny grows on sustainability and regulatory compliance, we increase our focus on responsible sourcing. Our plant staff track environmental performance from reagent selection to final waste disposal, aligning with international standards and preparing for audits from large multinational partners. Transparency doesn’t stop at the factory gate; it follows every shipment and batch record to the end customer, empowering their own compliance efforts and brand commitments.
We learn as much from failures as we do from smooth, trouble-free runs. Customers report back on downstream reaction yields, unexpected solubility trends, or shifts in side product formation. These insights get incorporated straight into process reviews and monthly plant meetings. Many improvements—such as refining the precipitation time or switching to a different drying technology—have come from customer comments, not just internal R&D. This open dialogue prevents complacency and sharpens our focus on details that matter most to chemists and engineers in the trenches.
Requests for custom cuts, alternate solvent residual limits, or enhanced documentation have led to new product variants over time. Some clients require fingerprint spectra for every single lot, or want to see full chromatograms rather than summary tables. As a manufacturer, we can respond quickly and decisively to these inquiries, returning more than just polite answers but actionable data and ongoing process updates.
Advances in medicinal chemistry and organic electronics show no signs of slowing, and the trusted building blocks of today often form the backbone of tomorrow’s discoveries. We expect 4-Bromomethyl-2-cyanobiphenyl to remain a crucial intermediate in both established markets and innovative new uses. As research continues to expand on the utility of the biphenyl scaffold and the reactivity offered by its bromo and cyano substituents, demand for clean, reliable material will only rise.
With decades at the sharp end of chemical manufacturing, we’ve seen waves of new applications transform once-niche intermediates into foundational reagents. We continue to innovate in production, product tracking, and risk management, aiming always to deliver a level of performance that supports cutting-edge research and commercial production alike.
By maintaining strong internal operations, offering detailed technical support, and aligning closely with end-user needs, we help chemists push the boundaries of what is possible with 4-Bromomethyl-2-cyanobiphenyl. Our approach gives them confidence not just in the bottle they open today, but in the quality and reliability of every lot yet to come.